IPO

New TPRY fund offers retail access to David Tepper's strategy plus a high-income options play, but does the reward outweigh the inherent risks?

The Singaporean facilities firm lands major residential deals, bolstering its recurring revenue as it navigates financial headwinds with a push in AI robotics.

Exceptional new drilling results bolster the Spanish Mountain Gold project, pointing to a larger resource and advancing its 'greenest mine' ambitions.

Cannara Biotech's graduation to the TSX, backed by strong financials and new analyst coverage, marks a pivotal moment for the company and the cannabis sector.

On the war's fourth anniversary, Kyivstar's board, including Mike Pompeo, visited Kyiv, reaffirming a $1B investment and honoring resilient employees.

Consolidated Lithium Metals aims to raise $17.07 million to advance its Quebec rare earth and lithium projects, capitalizing on key investor tax incentives.

With a key FDA decision looming and pivotal data on a second therapy imminent, Viridian is poised to reshape the multi-billion dollar Thyroid Eye Disease market.

Facing slow auto OEM cycles, Arbe Robotics names a new CEO and targets defense, robotaxis, and China to accelerate revenue from its high-res radar tech.

New analyses of Upstream Bio's verekitug aim to prove its true effectiveness for nasal polyps, setting the stage for a competitive showdown.

Teamsters at a Wyomissing dispensary walk out, sparking a new labor battle with cannabis giant Cresco Labs over wages and stable hours.

Titan International beat expectations in Q4, driven by a 21% surge in its construction division, and now eyes a strong 2026 as OEM destocking ends.

Riding a wave of record profits and market optimism, the Florida insurer prepares to lay out its future strategy to top institutional investors.

Vista Gold Corp. launches a major public offering to advance its massive Mt. Todd gold project in Australia, testing investor appetite for junior miners.

DelphX Capital Markets raises fresh capital for its innovative structured notes, navigating weak financials and a competitive market for hybrid securities.

Pennant Group posts record revenue and an aggressive 2026 outlook, but rapid expansion and regulatory headwinds present a complex path forward for the provider.

The diagnostics firm beat Q4 estimates with a 705% profit jump, driven by its Decipher and Afirma tests, and plans to launch two new products in 2026.

The water midstream leader's inaugural dividend signals financial confidence, but a look at its balance sheet reveals a complex picture of growth and debt.

FTAI Aviation reports a massive profit turnaround and raises its dividend, signaling confidence. But a pivot to power generation may be the real story.

Fintech giant Chime forecasts its first full year of GAAP profitability in 2026, propelled by its new ChimeCore platform, AI, and strong product growth.

With cash to last until 2027 but mounting losses, Alector stakes its future on its ABC platform and a pivotal Alzheimer's trial milestone.